Construction chemicals and materials contribute to the durability, safety, and efficiency of various building projects. These products encompass a wide range of substances and compounds used at different stages of construction. Construction materials typically include raw materials such as cement, steel, bricks, and concrete. These materials are used to form the structural foundation of buildings […]
Multimodal AI Market was valued at US$ 893.5 Million in 2023 and is expected to reach to US$ 10,550.20 Million by 2031; it is estimated to record a CAGR of 36.2% from 2023 to 2031
Application in Media and Entertainment Brings New Opportunities for Multimodal AI Market Growth The media and entertainment industries are striving to meet the evolved consumer demands for personalized content as well as an unlimited selection of OTT and streaming services. Multimodal AI can create and understand content in multiple formats or modes, including text, graphics, […]
Glaucoma therapeutics Market was valued at US$ 6.24 Billion in 2023 and is expected to reach to US$ 8.02 Billion by 2031; it is estimated to record a CAGR of 3.2% from 2023 to 2031
Glaucoma is a group of eye disorders caused due to the damage incurred to the optic nerve, which can eventually lead to total blindness. People with glaucoma may experience a gradual loss of nerve tissue, resulting in vision impairment or blindness if left untreated. Prostaglandin analogs are among the drugs widely recommended for effectively reducing […]
Plasma Therapy Market was valued at US$ 390.25 Million in 2022 and is expected to reach to US$ 1,097.64 Million by 2030; it is estimated to record a CAGR of 13.80% from 2022 to 2030
North America dominated the plasma therapy market in 2022. It is further expected to record the highest CAGR in the market during 2022–2030. The market in North America is segmented into the US, Canada, and Mexico. The US holds the largest market share of the global plasma therapy market. Market growth in the country is […]
Molecular Spectroscopy Market was valued at US$ 3,807.30 Million in 2022 and is expected to reach to US$ 5,586.37 Million by 2030; it is estimated to record a CAGR of 4.9% from 2022 to 2030
The demand for and use of molecular spectroscopy increased significantly during the COVID-19 pandemic. In July 2022, Bruker PhenoRisk launched PACS RuO, a research-only NMR test for molecular phenonomic research on blood samples from “long COVID-19” patients. The PhenoRisk PACS RuO test holds promise for exploring early-stage risk factors, monitoring longitudinal recovery, and prospective secondary […]